Goldman says these top tech stocks have plenty of upside ahead of earnings
Source: CNBC
Goldman Sachs highlighted Microsoft, Alphabet, Zeta Global, Palantir and CoreWeave as buy-rated technology stocks, citing AI opportunities and, for Zeta and Palantir, enterprise share gains and government demand. Zeta shares are up 67% this year, Microsoft more than 8%, Alphabet 2%, while Goldman said Alphabet investor concerns may be overdone and viewed a recent CoreWeave correction as a buying opportunity. The article reports analyst opinions ahead of company earnings, not new company results.
Analysis
This is a sell-side idea screen, not fresh evidence of improving fundamentals. The key distinction is who captures AI economics versus who must finance capacity: Microsoft can test whether Azure growth converts into returns on incremental capex, while CoreWeave’s upside depends more heavily on utilization, funding costs and the residual value of specialized infrastructure. That makes a broad “AI winners” basket vulnerable if investor focus shifts from demand to returns on capital.
Over the next few weeks, earnings are the catalyst, but guidance quality matters more than headline growth. For Microsoft, watch Azure growth alongside capex and capacity commentary; for Alphabet, Search trends and evidence that AI features monetize rather than divert queries; for Zeta, customer retention and measurable expansion, not AI positioning alone. Palantir’s government opportunity is conditional on awards becoming funded, recurring deployments. CoreWeave’s next-year demand signals would not by themselves settle longer-run asset-life or financing risk.
The contrarian risk is that optimism already embeds a smooth AI-spend cycle: enterprise consolidation can delay software decisions, and agent interfaces could pressure search economics before new products contribute meaningfully. No valuation or positioning data are provided, so avoid treating the analyst list as a ranking of expected returns. Prefer relative exposure to cash-generative platform economics over leveraged capacity claims, with event risk sized modestly.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
Key Decisions for Investors
- Prefer a relative-value expression: long Microsoft against an underweight in CoreWeave rather than buying both as equivalent AI beneficiaries. Reassess after Microsoft reports Azure growth, capex and returns commentary; reduce the relative position if Microsoft’s capex rises without improving growth or unit-economics evidence.
- Keep Alphabet on an earnings watchlist rather than adding solely on the analyst call. A constructive signal would be resilient Search monetization alongside credible AI product monetization; sustained Search deterioration without offsetting AI or Cloud contribution would falsify the recovery thesis.
- Treat Zeta’s reported share-gain narrative as unverified until results show durable customer expansion, retention and conversion of AI-related demand into revenue. Avoid chasing a sharp pre-earnings run-up; weakness on confirmed operating improvement may offer a better entry than momentum alone.
- For Palantir, distinguish announced government opportunities from funded, recurring deployments. Add only on evidence of contract conversion and sustained commercial or government growth; delayed awards or weaker deployment economics would undermine the thesis.
- Do not initiate a standalone CoreWeave position on this commentary alone. Track financing terms, capacity utilization, customer concentration and asset-life assumptions; worsening funding conditions or evidence of supply normalization ahead of demand would be reasons to avoid or cut exposure.
More News
- Nvidia's role as AI financier faces first big test as neoclouds take market hit
- AI funding fears rattle Wall Street. Here's how we're adjusting our portfolio
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- The UK is investing $134 million into an AI Biosecurity Lab
- CrowdStrike CEO's alarming prediction — plus, the sell-off spreads beyond tech
- Investing.com’s stocks of the week